To verify whether the LIM4 domain of FHL3 has reproducible cancer-promoting functions, we transiently transfected LIM2, LIM3, and LIM4 deletion mutants into Hep3B cells (Fig. S4A). This evidence concerns the gene FHL3 and cancer.